Skip to main content
. Author manuscript; available in PMC: 2018 Mar 5.
Published in final edited form as: Am J Prev Med. 2017 Dec;53(6 Suppl 2):S131–S142. doi: 10.1016/j.amepre.2017.06.020

Figure 2.

Figure 2

Frequencies of antihypertensive medicines by medicine classes in cost-effectiveness analyses published in 1990–2016 (n=76).

Note: Medicines were excluded for counting if they were used as adjunctive therapy for both intervention and control groups or as needed. All calcium channel blockers were dihydropyridine calcium channel blockers. All β-blockers were β1-selective β-blockers except propranolol, which is non-selective.